[{"id":"916e57cb-875f-4fd4-a594-bc1d45147dc4","acronym":"","url":"https://clinicaltrials.gov/study/NCT05969041","created_at":"2023-08-01T15:09:53.528Z","updated_at":"2024-07-02T16:35:23.063Z","phase":"Phase 1","brief_title":"Study of MT-302 in Adults With Advanced or Metastatic Epithelial Tumors","source_id_and_acronym":"NCT05969041","lead_sponsor":"Myeloid Therapeutics","biomarkers":" HER-2","pipe":" | ","alterations":" HER-2 negative","tags":["HER-2"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e HER-2 negative"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e MT-302"],"overall_status":"Recruiting","enrollment":" Enrollment 48","initiation":"Initiation: 08/02/2023","start_date":" 08/02/2023","primary_txt":" Primary completion: 08/31/2027","primary_completion_date":" 08/31/2027","study_txt":" Completion: 08/31/2028","study_completion_date":" 08/31/2028","last_update_posted":"2024-01-18"}]